QbD Based Method Development on an Agilent 1290 Infinity UHPLC System Combined with a Seamless Method Transfer to HPLC Using Intelligent System Emulation Technology

Applications | 2015 | Agilent TechnologiesInstrumentation
HPLC
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC
AGILENT SOLUTIONS FOR QUALITY-BY-DESIGN IMPLEMENTATION IN PHARMACEUTICAL DEVELOPMENT
Quality‑by‑Design Approach to Stability Indicating Method Development for Linagliptin Drug Product
Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin